Ascendis Pharma A (ASND) Gross Margin (2021 - 2026)
Ascendis Pharma A (ASND) reported Gross Margin of 91.85% for the quarter ended Jun 30, 2026, up 11.75 percentage points from 80.10% a year earlier but down 1.05 percentage points from the prior quarter.
Ascendis Pharma A (ASND) Gross Margin (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ascendis Pharma A's Gross Margin came in at 91.30%, up 6.51 percentage points year-over-year; for the year ended Dec 31, 2025, it was 86.82%, down 1.90 percentage points from the prior year.
- Gross Margin has a five-year change of -13.18 percentage points (years ended Dec 2020 to Dec 2025).
- By year, Gross Margin came in at 88.72% in the year ended Dec 31, 2024 (+5.36 pp), 83.36% in the year ended Dec 31, 2023 (+7.07 pp), 76.28% in the year ended Dec 31, 2022 (+21.58 pp) and 54.71% in the year ended Dec 31, 2021 (-45.29 pp).
- Five-year quarterly Gross Margin spans a low of 1.60% in the quarter ended Dec 31, 2021 and a high of 100.00% in the quarter ended Sep 30, 2021.
- Year over year, Gross Margin gained in five of the last eight quarters, with an average year-over-year change of +10.10 percentage points.
- The high point for year-over-year Gross Margin in five years was the quarter ended Dec 31, 2022 (a gain of 76.08 percentage points); the low point was the quarter ended Mar 31, 2022 (a drop of 62.19 percentage points).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 92.90% (quarter ended Mar 31, 2026), 90.47% (quarter ended Dec 31, 2025) and 89.54% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Ascendis Pharma A | 14.26 Bn | 10.50 Bn | 362.22 Mn | 91.85% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 91.85% |
| Mar 31, 2026 | 92.90% |
| Dec 31, 2025 | 90.47% |
| Sep 30, 2025 | 89.54% |
| Jun 30, 2025 | 80.10% |
| Mar 31, 2025 | 82.65% |
| Dec 31, 2024 | 91.94% |
| Sep 30, 2024 | 80.63% |
| Jun 30, 2024 | 68.15% |
| Mar 31, 2024 | 92.11% |
| Dec 31, 2023 | 39.06% |
| Sep 30, 2023 | 84.62% |
| Jun 30, 2023 | 72.72% |
| Mar 31, 2023 | 86.24% |
| Dec 31, 2022 | 77.68% |
| Sep 30, 2022 | 88.93% |
| Jun 30, 2022 | 82.37% |
| Mar 31, 2022 | 37.81% |
| Dec 31, 2021 | 1.60% |
| Sep 30, 2021 | 100.00% |
Ascendis Pharma A Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();